Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 242 entries
View as:

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Phase: N/A Priority: Normal
NCT ID: NCT00474058 Org: User:
Start: 05/31/07 End: 03/31/09 Due: 03/31/10

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00243945 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT01577264 Org: User:
Start: 08/31/11 End: 10/31/15 Due: 10/31/16

Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients

Phase: N/A Priority: Normal
NCT ID: NCT00394927 Org: User:
Start: 04/30/07 End: 08/31/07 Due: 08/31/08

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00542607 Org: User:
Start: 09/30/02 End: 12/31/02 Due: 12/31/03

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00717236 Org: User:
Start: 07/31/08 End: 03/31/11 Due: 03/31/12

Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01530022 Org: User:
Start: 05/31/12 End: 01/31/14 Due: 01/31/15

A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)

Phase: N/A Priority: Normal
NCT ID: NCT00160667 Org: User:
Start: 10/11/04 End: 01/05/06 Due: 01/05/07

A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00160641 Org: User:
Start: 11/30/05 End: 02/29/12 Due: 02/28/13

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT00238511 Org: User:
Start: 11/30/02 End: 01/31/05 Due: 01/31/06

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00552058 Org: User:
Start: 03/31/08 End: 11/30/09 Due: 11/30/10

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

Phase: N/A Priority: Normal
NCT ID: NCT00600509 Org: User:
Start: 01/31/01 End: 07/31/03 Due: 07/31/04

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00389831 Org: User:
Start: 08/31/06 End: 12/31/06 Due: 12/31/07

Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01764594 Org: User:
Start: 01/31/13 End: 08/31/14 Due: 08/31/15

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Phase: N/A Priority: Normal
NCT ID: NCT01618903 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00275236 Org: User:
Start: 11/30/05 End: 07/31/06 Due: 07/31/07

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00151879 Org: User:
Start: 02/28/05 End: 05/31/06 Due: 05/31/07

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Phase: N/A Priority: Normal
NCT ID: NCT01491113 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01408576 Org: User:
Start: 07/31/11 End: 02/29/16 Due: 02/28/17

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00152386 Org: User:
Start: 02/28/05 End: 10/31/06 Due: 10/31/07

Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00150735 Org: User:
Start: 06/30/02 End: 07/31/05 Due: 07/31/06

Effect of Brivaracetam in Photosensitive Epileptic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00401648 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting

Phase: N/A Priority: Normal
NCT ID: NCT00381758 Org: User:
Start: 05/31/02 End: 08/31/02 Due: 08/31/03

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

Phase: N/A Priority: Normal
NCT ID: NCT01113710 Org: User:
Start: 05/31/10 End: 07/31/11 Due: 07/31/12

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00152477 Org: User:
Start: 08/15/05 End: 06/25/09 Due: 06/25/10